These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21306743)

  • 21. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.
    Arnell K; Cesarini K; Lagerqvist-Widh A; Wester T; Sjölin J
    J Neurosurg Pediatr; 2008 May; 1(5):366-72. PubMed ID: 18447670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid shunt infections in children. A study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate.
    Ammirati M; Raimondi AJ
    Childs Nerv Syst; 1987; 3(2):106-9. PubMed ID: 3621226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components.
    Sciubba DM; Lin LM; Woodworth GF; McGirt MJ; Carson B; Jallo GI
    Neurosurg Focus; 2007 Apr; 22(4):E9. PubMed ID: 17613199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.
    Tuli S; Drake J; Lawless J; Wigg M; Lamberti-Pasculli M
    J Neurosurg; 2000 Jan; 92(1):31-8. PubMed ID: 10616079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functioning periods and complications of 246 cerebrospinal fluid shunting procedures in 208 children.
    Lee JY; Wang KC; Cho BK
    J Korean Med Sci; 1995 Aug; 10(4):275-80. PubMed ID: 8593208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.
    Govender ST; Nathoo N; van Dellen JR
    J Neurosurg; 2003 Nov; 99(5):831-9. PubMed ID: 14609161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid shunt complications.
    Güzelbağ E; Erşahin Y; Mutluer S
    Turk J Pediatr; 1997; 39(3):363-71. PubMed ID: 9339116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat cerebrospinal fluid shunt infection in children.
    Kulkarni AV; Rabin D; Lamberti-Pasculli M; Drake JM
    Pediatr Neurosurg; 2001 Aug; 35(2):66-71. PubMed ID: 11549916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
    Kulkarni AV; Drake JM; Lamberti-Pasculli M
    J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.
    Pople IK; Bayston R; Hayward RD
    J Neurosurg; 1992 Jul; 77(1):29-36. PubMed ID: 1607969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of endoscopic third ventriculostomy in previously shunted patients.
    Hader WJ; Walker RL; Myles ST; Hamilton M
    Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS168-74; discussion ONS174-5. PubMed ID: 18728596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of cerebrospinal fluid infection and the causative organisms following shunt procedures in Saudi Arabia. A retrospective study based on radiological findings.
    Al-Sharydah AM; Abu Melha YA; Al-Suhibani SS; Alojan AA; Al-Taei TH; Alfawaz II; AlShammari LT; Al-Jubran SA; Ammar AS
    Saudi Med J; 2020 Jun; 41(6):607-613. PubMed ID: 32518927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shunt infection: is there a near-miss scenario?
    Thompson DN; Hartley JC; Hayward RD
    J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection.
    Tulipan N; Cleves MA
    J Neurosurg; 2006 Jan; 104(1 Suppl):5-8. PubMed ID: 16509473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reappraisal of contributing factors leading to shunt infection.
    Khan I; Burhan M; Nadeem M
    J Ayub Med Coll Abbottabad; 2009; 21(1):66-8. PubMed ID: 20364744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
    Willis BK; Kumar CR; Wylen EL; Nanda A
    Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.